TMCO1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.11650030834676E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.58469999958599E-07 |
Normal-vs-Stage2 |
2.597200E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.117900E-02 |
Stage1-vs-Stage2 |
6.854400E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.152200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.479200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.09440001084505E-09 |
Normal-vs-AfricanAmerican |
4.0295000669488E-10 |
Normal-vs-Asian |
7.537900E-02 |
Caucasian-vs-AfricanAmerican |
4.166400E-01 |
Caucasian-vs-Asian |
3.708800E-01 |
AfricanAmerican-vs-Asian |
3.961900E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.204300E-04 |
Normal-vs-Female |
2.90769999966578E-07 |
Male-vs-Female |
9.821600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.978300E-04 |
Normal-vs-Extreme_Weight |
1.588080E-04 |
Normal-vs-Obese |
1.142850E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.581200E-01 |
Normal_Weight-vs-Obese |
8.472600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.007400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.457200E-01 |
Normal-vs-Age(41-60Yrs) |
3.53739999999769E-05 |
Normal-vs-Age(61-80Yrs) |
3.78420000000101E-05 |
Normal-vs-Age(81-100Yrs) |
1.189840E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.419000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.361200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.591000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.136400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.591600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.714400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.848400E-01 |
Normal-vs-Grade 3 |
6.518000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.004000E-01 |
Grade 2-vs-Grade 4 |
5.848400E-01 |
Grade 3-vs-Grade 4 |
6.518000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.83689999164483E-09 |
Normal-vs-N1 |
6.872500E-02 |
N0-vs-N1 |
4.223000E-01 |
|
|